Matches in SemOpenAlex for { <https://semopenalex.org/work/W2734448900> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2734448900 abstract "8582 Background: Multiple myeloma (MM) remains incurable despite novel therapies, highlighting the need for further identification of factors mediating disease progression and drug resistance. The bone marrow (BM) microenvironment confers growth, survival, and drug resistance in MM cells. Our recent study utilized in vitro and in vivo MM xenograft models to show that plasmacytoid dendritic cells (pDCs) were significantly increased in MM BM and promote MM growth (Chauhan et al., Cancer Cell 2009, 16:309). Importantly, we found increased IL-3 levels upon pDC-MM interaction, which in turn, trigger MM cell growth and pDCs survival. IL-3R is highly expressed on pDCs. We utilized SL-401, a novel biologic conjugate that targets IL-3R, to examine whether abrogation of IL-3–IL-3R signaling axis affects pDC-MM interaction and its tumor promoting sequelae. Methods: MM cell lines, patient MM cells, and pDCs from healthy donors or MM patients were utilized to study the anti-MM activity of SL-401. MM cells and pDCs were cultured alone or together in the presence or absence of SL-401, followed by analysis of cell growth or viability. Results: SL-401 significantly decreased the viability of pDCs at low concentrations (IC 50 : 0.83 ng/ml; P < 0.005, n = 3). SL-401 also decreased the viability of MM cells at clinically achievable doses. Co-culture of pDCs with MM cells induced growth of MM cell lines; and importantly, low doses (0.8 ng/ml) of SL-401 blocked MM cell growth-promoting activity of pDCs. MM patient-derived pDCs induced growth of MM cell lines and primary MM cells as well; conversely, SL-401 inhibited pDC-triggered MM cell growth (P < 0.005, n= 5). Tumor cells from 3 of the 5 patients were from patients whose disease was progressing while on bortezomib, dexamethasone, and lenalidomide therapies. In agreement with these results, SL-401 blocked pDC-induced growth of dexamethasone-resistant MM cell lines. Conclusions: Our study therefore provides the basis for directly targeting pDCs or blocking the pDC-MM interaction, as well as targeting MM, in novel therapeutic strategies with SL-401 to enhance MM cytotoxicity, overcome drug-resistance, and improve patient outcome." @default.
- W2734448900 created "2017-07-21" @default.
- W2734448900 creator A5001967177 @default.
- W2734448900 creator A5006765393 @default.
- W2734448900 creator A5009750077 @default.
- W2734448900 creator A5011905014 @default.
- W2734448900 creator A5032464400 @default.
- W2734448900 date "2013-05-20" @default.
- W2734448900 modified "2023-09-23" @default.
- W2734448900 title "Effect of a novel agent, SL-401, targeting interleukin-3 (IL-3)-receptor on plasmacytoid dendritic cell (pDC)-induced myeloma cell growth and drug resistance." @default.
- W2734448900 doi "https://doi.org/10.1200/jco.2013.31.15_suppl.8582" @default.
- W2734448900 hasPublicationYear "2013" @default.
- W2734448900 type Work @default.
- W2734448900 sameAs 2734448900 @default.
- W2734448900 citedByCount "0" @default.
- W2734448900 crossrefType "journal-article" @default.
- W2734448900 hasAuthorship W2734448900A5001967177 @default.
- W2734448900 hasAuthorship W2734448900A5006765393 @default.
- W2734448900 hasAuthorship W2734448900A5009750077 @default.
- W2734448900 hasAuthorship W2734448900A5011905014 @default.
- W2734448900 hasAuthorship W2734448900A5032464400 @default.
- W2734448900 hasConcept C114851261 @default.
- W2734448900 hasConcept C150903083 @default.
- W2734448900 hasConcept C203014093 @default.
- W2734448900 hasConcept C207001950 @default.
- W2734448900 hasConcept C2776364478 @default.
- W2734448900 hasConcept C2780007613 @default.
- W2734448900 hasConcept C502942594 @default.
- W2734448900 hasConcept C54355233 @default.
- W2734448900 hasConcept C62112901 @default.
- W2734448900 hasConcept C71924100 @default.
- W2734448900 hasConcept C86803240 @default.
- W2734448900 hasConcept C89423630 @default.
- W2734448900 hasConceptScore W2734448900C114851261 @default.
- W2734448900 hasConceptScore W2734448900C150903083 @default.
- W2734448900 hasConceptScore W2734448900C203014093 @default.
- W2734448900 hasConceptScore W2734448900C207001950 @default.
- W2734448900 hasConceptScore W2734448900C2776364478 @default.
- W2734448900 hasConceptScore W2734448900C2780007613 @default.
- W2734448900 hasConceptScore W2734448900C502942594 @default.
- W2734448900 hasConceptScore W2734448900C54355233 @default.
- W2734448900 hasConceptScore W2734448900C62112901 @default.
- W2734448900 hasConceptScore W2734448900C71924100 @default.
- W2734448900 hasConceptScore W2734448900C86803240 @default.
- W2734448900 hasConceptScore W2734448900C89423630 @default.
- W2734448900 hasLocation W27344489001 @default.
- W2734448900 hasOpenAccess W2734448900 @default.
- W2734448900 hasPrimaryLocation W27344489001 @default.
- W2734448900 hasRelatedWork W2081498322 @default.
- W2734448900 hasRelatedWork W2401332825 @default.
- W2734448900 hasRelatedWork W2563732924 @default.
- W2734448900 hasRelatedWork W2564744488 @default.
- W2734448900 hasRelatedWork W2567062423 @default.
- W2734448900 hasRelatedWork W2578019203 @default.
- W2734448900 hasRelatedWork W2737822227 @default.
- W2734448900 hasRelatedWork W2780169409 @default.
- W2734448900 hasRelatedWork W2798071244 @default.
- W2734448900 hasRelatedWork W2894660457 @default.
- W2734448900 hasRelatedWork W2898132937 @default.
- W2734448900 hasRelatedWork W2939681859 @default.
- W2734448900 hasRelatedWork W2964268954 @default.
- W2734448900 hasRelatedWork W2974619755 @default.
- W2734448900 hasRelatedWork W2989290646 @default.
- W2734448900 hasRelatedWork W3021465020 @default.
- W2734448900 hasRelatedWork W3025123046 @default.
- W2734448900 hasRelatedWork W3045790840 @default.
- W2734448900 hasRelatedWork W3156115445 @default.
- W2734448900 hasRelatedWork W3163529039 @default.
- W2734448900 isParatext "false" @default.
- W2734448900 isRetracted "false" @default.
- W2734448900 magId "2734448900" @default.
- W2734448900 workType "article" @default.